Status:
RECRUITING
EMPOWER 3: Improving Palliative Care Health Literacy and Utilization
Lead Sponsor:
Tulane University
Collaborating Sponsors:
American Cancer Society, Inc.
University Medical Center-New Orleans
Conditions:
Cancer
Neoplasm Malignant
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Through this award, Michael Hoerger, PhD, MSCR, a psychologist at the Tulane Cancer Center in Louisiana, will lead a study called EMPOWER 3 designed to test an educational intervention to help patient...
Eligibility Criteria
Inclusion
- Adult, age 18 or older
- Meets criteria for 2a or 2b. 2a) The patient's doctor believes they may be appropriate for palliative cancer care OR 2b) The patient has a new diagnosis, recurrence, or progression of cancer in the past 90 days AND any of the following:
- Advanced cancer, such as:
- Lung Cancer: Stage IIIB or IV non-small cell, or extensive stage small cell
- Breast Cancer: Stage IV
- Gastrointestinal (GI) Cancers: Unresectable stage III or stage IV
- Genitourinary (GU) Cancers: Stage IV
- Melanoma: Stage IV
- Hematologic Malignancies
- Leukemia (e.g., acute myeloid leukemia \[AML\], acute lymphoblastic leukemia \[ALL\], chronic myeloid leukemia (CML), chronic lymphocytic leukemia \[CLL\]): advanced stage, treatment refractory, poor prognosis cell type or chromosomal abnormalities, older age
- Lymphoma: Stage IV or treatment refractory Hodgkin's disease or non-Hodgkin's lymphoma Multiple Myeloma: elevated β2-microglobulin, albumin \<3.5, PCLI \>1%, CRP \>6µg/mL, elevated LDH, plasmablastic morphology, or abnormal chromosome 13
- Advanced heart, lung, renal (kidney), or liver disease
- Two or more severe symptoms (≥7 on 0-10 scale): pain, tiredness, drowsiness, nausea, bad appetite, shortness of breath, depression, or anxiety
- Patient can understand spoken or written English
- Patient receives care in southeast Louisiana
Exclusion
- Known history of receiving specialty palliative care or hospice
- Significant psychiatric or other co-morbid disease that would prohibit informed consent or participation in the study
- Unlikely to complete any follow-up surveys
Key Trial Info
Start Date :
March 31 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
August 1 2025
Estimated Enrollment :
172 Patients enrolled
Trial Details
Trial ID
NCT04733469
Start Date
March 31 2021
End Date
August 1 2025
Last Update
June 18 2024
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
University Medical Center
New Orleans, Louisiana, United States, 70112
2
Tulane University
New Orleans, Louisiana, United States, 70115